Entries of Fremont, Daved H. on the publication server

Kim, Arthur S. , Kafai, Natasha M. , Winkler, Emma S., Gilliland, Theron C., Cottle, Emily L., Earnest, James T., Jethva, Prashant N., Kaplonek, Paulina, Shah, Aadit P. , Fong, Rachel H., Davidson, Edgar, Malonis, Ryan J., Quiroz, Jose A., Williamson, Lauren E., Vang, Lo, Mack, Matthias, Crowe, James E., Doranz, Benjamin J., Lai, Jonathan R., Alter, Galit, Gross, Michael L., Klimstra, William B., Fremont, Daved H. and Diamond, Michael S. (2021) Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope. Cell 184 (17), 4414-4429.e19. Fulltext not available.

Earnest, James T., Holmes, Autumn C., Basore, Katherine, Mack, Matthias, Fremont, Daved H. and Diamond, Michael S. (2021) The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies. Cell Reports 35 (1), p. 108962. Fulltext not available.

Fox, Julie M. , Roy, Vicky , Gunn, Bronwyn M., Huang, Ling, Edeling, Melissa A., Mack, Matthias, Fremont, Daved H., Doranz, Benjamin J., Johnson, Syd, Alter, Galit and Diamond, Michael S. (2019) Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Science Immunology 4 (32), eaav5062. Fulltext not available.